India NewsOzempic, Wegovy: India's cheap weight-loss drugs could reshape global obesity fight loknath160574@gmail.com2 hours ago01 mins With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market. Source link Post navigation Previous: Sarke Chunar row: Lyricist Raqueeb Alam speaks out, says Hindi lyrics were ‘word by word’ translationNext: Exclusive: Amazon CEO sees AI doubling his prior AWS sales projections to $600 billion by 2036 Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
Ozempic, Wegovy: India’s cheap weight-loss drugs could reshape global obesity fight loknath160574@gmail.com6 hours ago 0
